Literature DB >> 12667218

Induction of murine thyroiditis by a non dominant E(k)-restricted peptide of human thyroglobulin.

Evangelos Karras1, George Carayanniotis, Peggy Lymberi.   

Abstract

We have previously shown that the human thyroglobulin (hTg) 20-mer peptide p2340 (aa 2340-2359) contains an epitope recognized by Tg-reactive B cells in patients with Graves' disease. The presence of several Ek-binding motifs within p2340 prompted us to examine whether this peptide can stimulate a T-cell response and elicit experimental autoimmune thyroiditis (EAT) in AKR/J (H-2k) mice. The peptide was found to be immunogenic at the T-cell level since it induced specific proliferative responses as well as interleukin-2 and interferon-gamma secretion in secondary cultures of peptide-primed lymph node cells (LNC). The p2340-specific proliferation was blocked almost completely by an Ek-specific monoclonal antibody (mAb) but was unaffected by a control Ak-specific mAb. Peptide-primed LNC did not respond to intact hTg and conversely, LNC primed in vivo with hTg did not respond to p2340 in culture, suggesting that p2340 contains non-dominant T-cell epitope(s). Direct subcutanaeous challenge of AKR/J mice (n = 9) with p2340 in adjuvant, elicited mild to moderate EAT (infiltration index of 1-2) and strong p2340-specific immunoglobulin G responses in all mice tested. These data delineate a new thyroiditogenic sequence within the carboxyl terminal region of hTg.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667218      PMCID: PMC1782930          DOI: 10.1046/j.1365-2567.2003.01607.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  Influence of a dominant cryptic epitope on autoimmune T cell tolerance.

Authors:  Stephen M Anderton; Nicholas J Viner; Philip Matharu; Pauline A Lowrey; David C Wraith
Journal:  Nat Immunol       Date:  2002-01-14       Impact factor: 25.606

2.  Enhanced iodination of thyroglobulin facilitates processing and presentation of a cryptic pathogenic peptide.

Authors:  Yang D Dai; Varada P Rao; George Carayanniotis
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

3.  Up to date with human thyroglobulin.

Authors:  S A van de Graaf; C Ris-Stalpers; E Pauws; F M Mendive; H M Targovnik; J J de Vijlder
Journal:  J Endocrinol       Date:  2001-08       Impact factor: 4.286

4.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.

Authors:  V T Oi; P P Jones; J W Goding; L A Herzenberg; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

5.  Enhancing or suppressive effects of antibodies on processing of a pathogenic T cell epitope in thyroglobulin.

Authors:  Y Dai; K A Carayanniotis; P Eliades; P Lymberi; P Shepherd; Y c Kong; G Carayanniotis
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

Review 6.  Thyroid antigens and autoimmunity.

Authors:  S Shulman
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

Review 7.  Pathogenic thyroglobulin peptides as model antigens: insights on the induction and maintenance of autoimmune thyroiditis.

Authors:  G Carayanniotis; Y C Kong
Journal:  Int Rev Immunol       Date:  2000       Impact factor: 5.311

8.  Autoimmune murine thyroiditis relation to histocompatibility (H-2) type.

Authors:  A O Vladutiu; N R Rose
Journal:  Science       Date:  1971-12-10       Impact factor: 47.728

9.  Cellular basis of the genetic control of immune responsiveness to murine thyroglobulin in mice.

Authors:  A O Vladutiu; N R Rose
Journal:  Cell Immunol       Date:  1975-05       Impact factor: 4.868

10.  Delineation of five thyroglobulin T cell epitopes with pathogenic potential in experimental autoimmune thyroiditis.

Authors:  Panayotis Verginis; Marianne M Stanford; George Carayanniotis
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

View more
  7 in total

1.  Fine epitope mapping within the pathogenic thyroglobulin peptide 2340-2359: minimal epitopes retaining antigenicity across various MHC haplotypes are not necessarily immunogenic.

Authors:  Aikaterini Hatzioannou; Maria Alevizaki; George Carayanniotis; Peggy Lymberi
Journal:  Immunology       Date:  2012-03       Impact factor: 7.397

2.  Efficacy of HLA-DRB1∗03:01 and H2E transgenic mouse strains to correlate pathogenic thyroglobulin epitopes for autoimmune thyroiditis.

Authors:  Yi-chi M Kong; Nicholas K Brown; Jeffrey C Flynn; Daniel J McCormick; Vladimir Brusic; Gerald P Morris; Chella S David
Journal:  J Autoimmun       Date:  2011-06-17       Impact factor: 7.094

3.  A novel pathogenic peptide of thyroglobulin (2208-2227) induces autoreactive T-cell and B-cell responses in both high and low responder mouse strains.

Authors:  Ioannis Kanistras; Aikaterini Hatzioannou; Peggy Lymberi
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 4.  Thyroglobulin as an autoantigen: what can we learn about immunopathogenicity from the correlation of antigenic properties with protein structure?

Authors:  Fabrizio Gentile; Marisa Conte; Silvestro Formisano
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

5.  A novel H2A-E+ transgenic model susceptible to human but not mouse thyroglobulin-induced autoimmune thyroiditis: identification of mouse pathogenic epitopes.

Authors:  Nicholas K Brown; Daniel J McCormick; Vladimir Brusic; Chella S David; Yi-Chi M Kong
Journal:  Cell Immunol       Date:  2008-04-14       Impact factor: 4.868

6.  Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice.

Authors:  Francesca Menconi; Maria C Monti; David A Greenberg; Taiji Oashi; Roman Osman; Terry F Davies; Yoshiyuki Ban; Eric M Jacobson; Erlinda S Concepcion; Cheuk Wun Li; Yaron Tomer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-08       Impact factor: 11.205

7.  Pathogenicity of a human thyroglobulin peptide (2340-2359) in mice with high or low genetic susceptibility to thyroiditis.

Authors:  Aikaterini Hatzioannou; Elisavet Liakata; Evangelos Karras; Apollon Thrasyvoulides; Maria Alevizaki; Peggy Lymberi
Journal:  Immunology       Date:  2007-06-29       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.